Low‐dose empagliflozin as adjunct‐to‐insulin therapy in type 1 diabetes: A valid modelling and simulation analysis to confirm efficacy
暂无分享,去创建一个
J. Rosenstock | J. Skyler | L. Laffel | J. George | B. Perkins | V. Nock | M. Riggs | Ahmed Elmokadem | J. Marquard | D. Neubacher | N. Soleymanlou | Rena J Eudy-Byrne | C. Johnston | Karl‐Heinz Liesenfeld